News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,478 Results
Type
Article (13971)
Company Profile (102)
Press Release (252405)
Section
Business (88646)
Career Advice (465)
Deals (15429)
Drug Delivery (66)
Drug Development (36820)
Employer Resources (49)
FDA (6304)
Job Trends (6219)
News (151167)
Policy (14089)
Tag
Academia (448)
Alliances (23371)
Alzheimer's disease (376)
Approvals (6326)
Artificial intelligence (86)
Bankruptcy (146)
Best Places to Work (4382)
Breast cancer (69)
Cancer (504)
Cardiovascular disease (52)
Career advice (407)
Cell therapy (73)
Clinical research (30932)
Collaboration (273)
Compensation (114)
COVID-19 (754)
C-suite (90)
Data (501)
Diabetes (66)
Diagnostics (1336)
Drug discovery (46)
Drug pricing (60)
Earnings (31945)
Events (37559)
Executive appointments (309)
FDA (6620)
Funding (174)
Gene therapy (85)
GLP-1 (322)
Government (1284)
Healthcare (3625)
Infectious disease (781)
Inflammatory bowel disease (52)
Interviews (58)
IPO (5913)
Job creations (2061)
Job search strategy (372)
Layoffs (176)
Legal (3443)
Lung cancer (71)
Manufacturing (126)
Medical device (1319)
Medtech (1321)
Mergers & acquisitions (9658)
Metabolic disorders (211)
Neuroscience (520)
NextGen: Class of 2025 (1604)
Non-profit (633)
Northern California (601)
Obesity (122)
Opinion (116)
Patents (86)
People (28966)
Pharmaceutical (65)
Phase I (8054)
Phase II (13115)
Phase III (11706)
Pipeline (272)
Policy (52)
Postmarket research (1408)
Preclinical (3219)
Radiopharmaceuticals (117)
Rare diseases (141)
Real estate (2665)
Regulatory (10039)
Research institute (579)
Resumes & cover letters (56)
Southern California (595)
Startups (1648)
United States (6081)
Vaccines (133)
Weight loss (88)
Date
Last 7 days (232)
Last 30 days (978)
Last 365 days (12479)
2025 (1734)
2024 (12642)
2023 (14374)
2022 (19732)
2021 (20249)
2020 (19240)
2019 (15132)
2018 (11851)
2017 (13988)
2016 (13239)
2015 (15586)
2014 (12541)
2013 (10657)
2012 (11519)
2011 (12065)
2010 (11025)
Location
Africa (313)
Asia (20011)
Australia (2594)
California (1433)
Canada (792)
China (185)
Colorado (60)
Connecticut (61)
Europe (39286)
Florida (251)
Illinois (165)
Indiana (114)
Japan (72)
Kansas (53)
Maryland (214)
Massachusetts (1221)
Michigan (132)
Minnesota (85)
New Jersey (612)
New York (405)
North Carolina (341)
Northern California (601)
Pennsylvania (361)
South America (502)
Southern California (595)
Texas (185)
Virginia (57)
Washington State (100)
266,478 Results for "arbor pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor
The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park.
June 6, 2024
·
3 min read
BioMidwest
Daicel Arbor Biosciences launches new myTXTL® kits to accelerate protein expression
Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering.
June 25, 2024
·
2 min read
Deals
Arbor Biotechnologies Announces Acquisition of Serendipity
Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, announced the acquisition of Serendipity Biosciences, a private biotechnology company focused on the discovery of unique gene editing technologies.
May 8, 2024
·
3 min read
Press Releases
Arbor Biotechnologies Announces FDA Acceptance of IND Application for ABO-101 for the Treatment of Primary Hyperoxaluria Type 1
December 19, 2024
·
3 min read
FDA
Blue Arbor Technologies Receives FDA Breakthrough Device Designation and TAP Enrollment for the RESTORE™ Neuromuscular Interface System
Blue Arbor Technologies Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the RESTORE™ Neuromuscular Interface System for people with upper limb loss.
April 24, 2024
·
6 min read
Business
Allogene, Arbor Team to Develop Off-the-Shelf CAR-T Therapies with CRISPR
Allogene Therapeutics and Arbor Biotechnologies will use their allogeneic CAR T and next-generation gene-editing platforms to develop novel off-the-shelf CAR-T therapies for autoimmune diseases.
March 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Arbor Biotechnologies Announces FDA Orphan Drug and Rare Pediatric Disease Designations Granted to ABO-101 for the Treatment of Primary Hyperoxaluria Type 1 (PH1) and Upcoming Presentations at the 20th Congress of the International Pediatric Nephrology Association (IPNA)
February 5, 2025
·
3 min read
Business
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
Allogene Therapeutics, Inc. and Arbor Biotechnologies, Inc. today announced a non-exclusive, global gene editing licensing agreement for use of Arbor’s proprietary CRISPR gene-editing technology in Allogene’s next generation AlloCAR T platform for the treatment of autoimmune disease (AID).
March 12, 2024
·
6 min read
Business
Arbor Biotechnologies Announces Collaboration with Ginkgo Bioworks to Advance the Discovery and Development of Precision Gene Editors
Arbor today announced a collaboration with Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, to leverage Ginkgo’s comprehensive Codebase and automated Foundry to jointly optimize Arbor’s novel precision editors.
December 12, 2023
·
7 min read
Business
4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT) and Arbor Biotechnologies, Inc. (Arbor) today announced a strategic partnership focused on advancing new AAV-based gene-editing therapies for central nervous system (CNS) diseases with high unmet medical needs in both rare and common disease populations.
January 3, 2024
·
9 min read
1 of 26,648
Next
